• Call for Abstract

Call for Abstract

Call for Abstract

How to submit abstracts

All submissions will be accepted online.
Please click the "Abstract Submission" button at the bottom of this page.

When to submit abstracts

The deadline for submissions will not be extended. Please submit abstracts before the deadline.

October 1 (Tue), 2019 at noon – November 25 (Mon), 2019 at noon
in Japan standard time

Abstract submission has been closed.
Thank you for your submission.

Abstract submission guidelines

  1. Abstract restrictions
    Submit ONLY ONE abstract per first author, with the exception of co-presenters.
    *Registration by first author in person is required.
    Multiple abstract submissions from a single organization are welcome.
  2. Information to submit
    • Language of presentation: English
    • Presentation format: oral or poster presentation
    • Principal presenter and co-presenter names: No more than 20 presenters
    • Principal presenter and co-presenter affiliations: No more than 10 affiliations
    • Abstract title: No more than 100 half - width (1-byte) characters in English
    • Abstract
      • - Abstracts should be submitted in English.
      • - Abstracts should be no more than1,600 half - width (1-byte) characters in English.
      • - The abstract should be divided into succinct sections for "Objective," "Methods," "Results," "Conclusions," and so on. There is no need for line breaks after headings or between the lines. It wouldn't be reflected on the book of abstracts, even if you used the tag to add a line break.
      • - Incomplete abstracts (i.e. abstracts with typos, with missing letters/words, lacking concrete numbers, without "Objective," "Methods," "Results," and "Conclusions" sections, etc.) will not be accepted, so please be especially careful when preparing abstracts for submission.
  3. Guidelines for ethical considerations
    Depending on the nature of the research to be presented, it may be necessary to adhere to ethical guidelines (for clinical research, human genome/genetic analysis research, immunological research, clinical research using human stem cells, etc.) established by the Ministry of Health, Labour and Welfare or other agencies, as well as the ethical rules (including those for animal research, etc.) set forth by presenters' affiliations, and to seek prior review and approval from their institution's ethical review boards, etc. For further information, please see "Ethical Considerations in Abstracts for the Annual Meeting of the Japanese Society of Neurology"
  4. Guidelines for abstract contents
    • Abstract(s) must not have been presented at annual meetings including other societies at the time of submission.
    • Submitted abstracts will be peer-reviewed, so please avoid any mention of your affiliation in the title or body of your abstract.
    • When referring to drugs by name, please be certain to use the generic name.
    • Please report the actual number of cases and/or laboratory animals/test specimens at the time of the experiment.
    • In principle, General Session Abstracts should not report on single cases. However, upon review, such a presentation may be accepted if the case has been substantively examined from a symptomological and scientific perspective.
    • If the content infringes upon patients' personal information, informed consent must be obtained from the patient or their representative and the presentation must carefully avoid identifying any individuals. We prohibit presentations that include information, such as hospitalization dates or age, that could be used to identify individuals.
    • The Committee of Reviewers will review all the submitted abstracts, and the decision on abstract acceptance will be made by the Program Committee. Please note that a submitted abstract could be rejected depends on reviewing result.
  5. Others
    • No matter what the reason, revisions to abstracts after submission deadline will not be accepted. The office will not request revisions for accepted abstracts. Submitted abstracts will appear as accepted in Clinical Neurology (vol. 60, issue Supplement). Revisions to abstracts after the annual meeting will not be accepted, so please prepare your abstracts with care.
    • The registration ID number and password are automatically generated, and sent to the first author by E-mail. You can view/edit/delete abstract at any time until the final deadline.
  6. Best presentation awards
    The JSN reviewers will give the best presentation awards to the best presenters (oral and poster) in nominees. The awards ceremony will be held in the Closing Ceremony on Sep.2 (Wednesday).

Disclosures of conflicts of interest

To promote appropriate forms of collaborative clinical research between industry and academia and ensure neutrality and transparency in presentations on clinical research findings based on sound science and ethics, all presenters are expected to disclose any "conflicts of interest" (COI).

When submitting proposals, please select "yes" or "no" in the field for "Do you have any conflicts of interest?" on the screen. If "yes," then please download and fill out the COI application form and send it to The Japanese Society of Neurology Secretariat office (jsn-office@gol.com) as an e-mail attachment no later than December 6 (Friday), 2019. Technical questions regarding conflicts of interest should be directed to the society office as well.

Notification of Acceptance

Once the program is finalized, acceptance/non-acceptance of the abstracts will be announced on this webpage around the middle of February. Please make a note of the "Abstract Entry Number (number of seven digits)" which will be shown in the E-mail sent right after the completion of your abstract submission. With the Abstract Entry Number, you will be able to find the information such as presentation schedule, format and location on this webpage.
The decision on abstract acceptance is entirely up to the Program Committee.
No matter what the reason, request for change of your presentation schedule will not be accepted.
Online pre-registration by July 10 is required of all presenting authors (first authors.) Please understand that the abstracts of unregistered presenting authors on July 10 (Friday) will be withdrawn.

Information for Speakers

The organizing committee of the 61st Annual Meeting of the Japanese Society of Neurology has decided to cancel on-site and online oral/poster presentations from overseas, considering current situation of COVID-19 infection.
All accepted abstracts will be published in the proceedings of the conference.

In addition, we regret to inform you that we have also decided to cancel the travel grant provision.

For more information, please check the Important Information page.

Oral presentations
  • PC projectors are available for use.
  • Video projectors are not available, but video can be projected from PCs.
  • Presentation data must be provided on media (USB flash memory or CD-R). In the case of video, please bring your own PC.
  • Presentations should adhere to ethical rules of research as well as rules for protecting personal information.
  • Whether or not a presenter has any conflicts of interest, they must include a conflict-of-interest disclosure slide in their presentation. Please use "Form 4-A" or "Form 4-B."

Abstract Submission (View / Edit / Delete)

Abstract submission

How to contact us

For inquiries regarding abstract submissions (free papers)

The Japanese Society of Neurology Secretariat

Ichimaru Bldg., 2-31-21 Yushima, Bunkyo-ku, Tokyo 113-0034